1.	Phase III Study of High-Dose CTX plus GM-CSF with vs without WR-2721 Chemoprotection in Patients with Advanced Malignancies Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-9160, CALGB-9160
2.	Phase I/II Study of IL-1A/MITO with Ketoconazole for Metastatic Colorectal and Prostate Carcinomas (Summary Last Modified 08/95) Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CRB-9202, NCI-T94-0090N, T94-0090
3.	Phase II Study of Recombinant Human Interleukin-11 with Sargramostim (GM-CSF) for Acute Myeloid Leukemia Patients Receiving High-Dose Cytarabine During Induction and Consolidation Chemotherapy Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18-55 Sponsor: NCI Protocol IDs: E-3997, E3997
4.	Phase II Randomized Study of Leridistim vs Filgrastim (G-CSF) in Older Patients With Acute Myeloid Leukemia Receiving Cytarabine and Daunorubicin. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 55 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-99055, MCC-11506, SC-IN5-99-12-011, NCI-G99-1652, NCT00004215
5.	Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069246, CALGB-10003, NCT00031980
6.	Phase II Study of CDDP/WR-2721 in Patients with Metastatic Breast Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 to 72 Sponsor: NCI Protocol IDs: EST-8188
7.	Phase II Pilot Study of a Modified Orange Regimen in the Treatment of Childhood Nonlocalized Nonlymphoblastic Lymphoma Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 21 and under Sponsor: NCI Protocol IDs: CCG-5911
8.	Phase II Randomized Study to Evaluate the Hematopoietic Effect of IL-1A on Granulothrombocytopenia Associated with Hemibody Irradiation Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9206, RTOG-92-06
9.	G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000574000, RTOG-0623, NCT00554463
10.	Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Closed Age: 1 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000066668, CCG-09717, NCT00003597
11.	Phase I Trial of WR-2721 with High-Dose CDDP in Patients with non-Small Cell Lung Cancer and Other Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CCUM-8816, NCI-T88-0194D, T88-0194
12.	Phase I Trial of CBDCA/WR-2721 in Patients with Advanced Malignancies Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CCF-RPC-3144, NCI-T89-0153O, T89-0153
13.	Phase I Study of Doxorubicin with ICRF-187 Cardioprotection plus GM-CSF in Patients with Advanced Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NYU-T89-0049, NCI-T89-0049D, T89-0049
14.	Phase I Trial of High-Dose DOX plus Recombinant GM-CSF plus ADR-529 in Patients with Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-8983, CALGB-8983
15.	Phase I Study of CBDCA/CDDP with Toxicity Attenuation with WR-2721 in Patients with Metastatic Carcinomas Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: LAC-USC-0C903, NCI-T89-0028D, T89-0028
16.	Phase I Study of Methylene Blue for the Treatment of Hypotension in Patients with Advanced Cancer Receiving IL-1A Support for CBDCA Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: BRMP-9211, NCI-T92-0216N, T92-0216
17.	Phase I Pilot Pharmacokinetic Study of Carboxypeptidase G2 Rescue of High-Dose MTX in Patients with Recurrent Primary CNS Lymphoma Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-93040, NCI-T92-0244D, T92-0244
18.	Pilot Study of GM-CSF to Ameliorate Radiation-Related Granulocytopenia in Patients with Lymphoma (Summary Last Modified 01/91) Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-90-C-134, NCI-T90-0015N, T90-0015